Know Cancer

or
forgot password

Cyberknife Radiosurgery and Quality of Life


N/A
18 Years
N/A
Open (Enrolling)
Both
Bone Cancer, Central Nervous System Cancer

Thank you

Trial Information

Cyberknife Radiosurgery and Quality of Life


Inclusion Criteria:



- Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.

- There are no age or gender restrictions.

- There are no life expectancy restrictions.

- Karnofsky Performance Status greater than 40.

- Negative pregnancy test or clinically assessed as not pregnant.

- Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:

- Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)

- Other investigational medications or treatments will be noted, but will not preclude
inclusion.

- Pregnant or nursing patients will be not be included in the study due to radiation
exposure.

Type of Study:

Observational

Study Design:

Observational Model: Ecologic or Community, Time Perspective: Prospective

Principal Investigator

Steven Daniel Chang

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

SPN0002

NCT ID:

NCT01163539

Start Date:

September 2010

Completion Date:

September 2012

Related Keywords:

  • Bone Cancer
  • Central Nervous System Cancer
  • Bone Neoplasms
  • Osteosarcoma
  • Nervous System Neoplasms
  • Central Nervous System Neoplasms

Name

Location

Stanford University School of Medicine Stanford, California  94305-5317